Global Biomarkers Market 2022-2028

The global biomarkers market is likely to register a CAGR of over 12.3% with an incremental growth of USD 48 billion during the forecast period 2022-2028.

A biomarker is a biological characteristic that is objectively measured and evaluated as an indicator of normal biological or pathological processes, or a response to a therapeutic intervention. Examples include patterns of gene expression, levels of a particular protein in body fluids, or changes in electrical activity in the brain. The global biomarkers market is likely to register a CAGR of over 12.3% with an incremental growth of USD 48 billion during the forecast period 2022-2028. The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global biomarkers market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the biomarkers industry.

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, technology, disease, end user, and region. The global market for biomarkers can be segmented by product: consumables, instruments, services, software. Among these, the consumables segment was accounted for the highest revenue generator in 2021. Biomarkers market is further segmented by technology: genomics, proteomics, metabolomics, imaging, others. The proteomics segment is estimated to account for the largest share of the global biomarkers market. Based on disease, the biomarkers market is segmented into: cancer, cardiovascular and metabolic diseases, neurodegenerative diseases, infectious diseases, autoimmune diseases, others. The cancer segment held the largest share of the global biomarkers market in 2021 and is anticipated to hold its share during the forecast period. On the basis of end user, the biomarkers market also can be divided into: biopharmaceutical and biotech companies, CROs, hospitals and diagnostics, research and academic institutes. In 2021, the hospitals and diagnostics segment made up the largest share of revenue generated by the biomarkers market. Biomarkers market by region is categorized into: Emerging Region, Europe, North America. By product: - consumables - instruments - services - software By technology: - genomics - proteomics - metabolomics - imaging - others

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Arun Kalwani

Arun Kalwani

Research Analyst

By disease: - cancer - cardiovascular and metabolic diseases - neurodegenerative diseases - infectious diseases - autoimmune diseases - others By end user: - biopharmaceutical and biotech companies - CROs - hospitals and diagnostics - research and academic institutes By region: - Emerging Region - Europe - North America

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Arun Kalwani

The market research report covers the analysis of key stake holders of the global biomarkers market. Some of the leading players profiled in the report include Abbott Laboratories Inc., Agilent Technologies Inc., Bayer AG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corp., Bruker Corp., Canon Medical Systems Corporation, Danaher Corporation, F. Hoffmann-La Roche Ltd, FUJIFILM VisualSonics Inc., GE Healthcare, Illumina, Inc., JEOL Ltd., Koninklijke Philips N.V., Oxford Nanopore Technologies Limited, PerkinElmer, Inc., QIAGEN N.V., Shimadzu Corporation, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Waters Corporation, among others. *REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES Historical & Forecast Period This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year. Scope of the Report - To analyze and forecast the market size of the global biomarkers market. - To classify and forecast the global biomarkers market based on product, technology, disease, end user, region. - To identify drivers and challenges for the global biomarkers market. - To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global biomarkers market. - To identify and analyze the profile of leading players operating in the global biomarkers market. Why Choose This Report - Gain a reliable outlook of the global biomarkers market forecasts from 2022 to 2028 across scenarios. - Identify growth segments for investment. - Stay ahead of competitors through company profiles and market data. - The market estimate for ease of analysis across scenarios in Excel format. - Strategy consulting and research support for three months. - Print authentication provided for the single-user license.

Table of Contents

  • TABLE OF CONTENTS
  • FIGURES AND TABLES
  • PART 1. INTRODUCTION
  • · Report description
  • · Objectives of the study
  • · Market segment
  • · Years considered for the report
  • · Currency
  • · Key target audience
  • PART 2. METHODOLOGY
  • PART 3. EXECUTIVE SUMMARY
  • PART 4. MARKET OVERVIEW
  • · Introduction
  • · Drivers
  • · Restraints
  • · Impact of COVID-19 pandemic
  • PART 5. MARKET BREAKDOWN BY PRODUCT
  • · Consumables
  • · Instruments
  • · Services
  • · Software
  • PART 6. MARKET BREAKDOWN BY TECHNOLOGY
  • · Genomics
  • · Proteomics
  • · Metabolomics
  • · Imaging
  • · Others
  • PART 7. MARKET BREAKDOWN BY DISEASE
  • · Cancer
  • · Cardiovascular and metabolic diseases
  • · Neurodegenerative diseases
  • · Infectious diseases
  • · Autoimmune diseases
  • · Others
  • PART 8. MARKET BREAKDOWN BY END USER
  • · Biopharmaceutical and biotech companies
  • · CROs
  • · Hospitals and diagnostics
  • · Research and academic institutes
  • PART 9. MARKET BREAKDOWN BY REGION
  • · Emerging Region
  • · Europe
  • · North America
  • PART 10. KEY COMPANIES
  • · Abbott Laboratories Inc.
  • · Agilent Technologies Inc.
  • · Bayer AG
  • · Becton, Dickinson and Company
  • · Bio-Rad Laboratories, Inc.
  • · Bio-Techne Corp.
  • · Bruker Corp.
  • · Canon Medical Systems Corporation
  • · Danaher Corporation
  • · F. Hoffmann-La Roche Ltd
  • · FUJIFILM VisualSonics Inc.
  • · GE Healthcare
  • · Illumina, Inc.
  • · JEOL Ltd.
  • · Koninklijke Philips N.V.
  • · Oxford Nanopore Technologies Limited
  • · PerkinElmer, Inc.
  • · QIAGEN N.V.
  • · Shimadzu Corporation
  • · Siemens Healthineers AG
  • · Thermo Fisher Scientific Inc.
  • · Waters Corporation
  • *REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
  • DISCLAIMER

Why Bonafide Research?

  • Our seasoned industry experts bring diverse sector experience, tailoring methodologies to your unique challenges.
  • Leveraging advanced technology and time-tested methods ensures accurate and forward-thinking insights.
  • Operating globally with a local touch, our research spans borders for a comprehensive view of international markets.
  • Timely and actionable insights empower swift, informed decision-making in dynamic market landscapes.
  • We foster strong client relationships based on trust, transparency, and collaboration.
  • Our dedicated team adapts and evolves strategies to meet your evolving needs.
  • Upholding the highest standards of ethics and data security, we ensure confidentiality and integrity throughout the research process.

How client has rates us?

Requirement Gathering & Methodology
92%
Data Collection Techniques
97%
Our Research Team & Data Sourcing
93%
Data Science & Analytical Tools
81%
Data Visualization & Presentation Skills
86%
Project/ Report Delivery & After Sales Services
88%
Logo

Global Biomarkers Market 2022-2028

We are friendly and approachable, give us a call.